{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:09:23Z","timestamp":1794377363690,"version":"4.9.0"},"reference-count":68,"publisher":"European Respiratory Society (ERS)","issue":"166","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2022,9,22]]},"published-print":{"date-parts":[[2022,12,31]]},"abstract":"<jats:p>Severe community-acquired pneumonia is the most life-threatening form of community-acquired pneumonia, characterised by intensive care unit admission and high morbidity and mortality. In this review article, we cover in depth six aspects of severe community-acquired pneumonia that are still controversial: use of PCR molecular techniques for microbial diagnosis; the role of biomarkers for initial management; duration of treatment, macrolides or quinolones in the initial empirical antibiotic therapy; the use of prediction scores for drug-resistant pathogens to modify initial empiric therapy; the use of noninvasive mechanical ventilation and high-flow nasal oxygen; and the use of corticosteroids as adjunctive therapy in severe community-acquired pneumonia.<\/jats:p>","DOI":"10.1183\/16000617.0123-2022","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T09:25:15Z","timestamp":1671009915000},"page":"220123","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":110,"title":["Severe community-acquired pneumonia"],"prefix":"10.1183","volume":"31","author":[{"given":"Michael S.","family":"Niederman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8643-2167","authenticated-orcid":false,"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"2024102404082962000_31.166.220123.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST"},{"key":"2024102404082962000_31.166.220123.2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0306"},{"key":"2024102404082962000_31.166.220123.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.051"},{"key":"2024102404082962000_31.166.220123.4","doi-asserted-by":"crossref","first-page":"e0191721","DOI":"10.1371\/journal.pone.0191721","article-title":"Severe community-acquired pneumonia: characteristics and prognostic factors in ventilated and non-ventilated patients","volume":"13","author":"Ferrer","year":"2018","journal-title":"PLoS One"},{"key":"2024102404082962000_31.166.220123.5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia","volume":"7","author":"Torres","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2024102404082962000_31.166.220123.6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-0041-1739359","article-title":"Classical and molecular techniques to diagnose HAP\/VAP","volume":"43","author":"Renaud","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"2024102404082962000_31.166.220123.7","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-216990"},{"key":"2024102404082962000_31.166.220123.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115179"},{"key":"2024102404082962000_31.166.220123.9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2213-2600(17)30120-0","article-title":"Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial","volume":"5","author":"Brendish","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024102404082962000_31.166.220123.10","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00135-20"},{"key":"2024102404082962000_31.166.220123.11","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1038\/s41598-022-08003-8","article-title":"Evaluation of microbiome enrichment and host DNA depletion in human vaginal samples using Oxford Nanopore's adaptive sequencing","volume":"12","author":"Marquet","year":"2022","journal-title":"Sci Rep"},{"key":"2024102404082962000_31.166.220123.12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13054-022-04006-z","article-title":"Diagnostic concordance between BioFire FilmArray Pneumonia Panel and culture in patients with COVID-19 pneumonia admitted to intensive care units: the experience of the third wave in eight hospitals in Colombia","volume":"26","author":"Molina","year":"2022","journal-title":"Crit Care"},{"key":"2024102404082962000_31.166.220123.13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201709-1908OC"},{"key":"2024102404082962000_31.166.220123.14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/17476348.2.5.565","article-title":"Biomarkers in the management of pneumonia","volume":"2","author":"Christ-Crain","year":"2008","journal-title":"Expert Rev Respir Med"},{"key":"2024102404082962000_31.166.220123.15","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-020-0770-3"},{"key":"2024102404082962000_31.166.220123.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61879-1"},{"key":"2024102404082962000_31.166.220123.17","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00053-0"},{"key":"2024102404082962000_31.166.220123.18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1164\/rccm.202004-1201OC","article-title":"Procalcitonin to reduce long-term infection-associated adverse events in sepsis. A randomized trial","volume":"203","author":"Kyriazopoulou","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404082962000_31.166.220123.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.12.029"},{"key":"2024102404082962000_31.166.220123.20","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000005337"},{"key":"2024102404082962000_31.166.220123.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.04.010"},{"key":"2024102404082962000_31.166.220123.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2008.01.003"},{"key":"2024102404082962000_31.166.220123.23","doi-asserted-by":"crossref","first-page":"e28880","DOI":"10.1097\/MD.0000000000028880","article-title":"Prognostic value of serum amyloid A in COVID-19: a meta-analysis","volume":"101","author":"Li","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2024102404082962000_31.166.220123.24","doi-asserted-by":"publisher","DOI":"10.1159\/000320319"},{"key":"2024102404082962000_31.166.220123.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200603-350OC"},{"key":"2024102404082962000_31.166.220123.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406330"},{"key":"2024102404082962000_31.166.220123.27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","article-title":"\u03b2-Lactam monotherapy vs \u03b2-lactam\u00ad\u2013macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial","volume":"174","author":"Garin","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2024102404082962000_31.166.220123.28","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3182a66b9b"},{"key":"2024102404082962000_31.166.220123.29","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.2.940"},{"key":"2024102404082962000_31.166.220123.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200311-1578OC"},{"key":"2024102404082962000_31.166.220123.31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chest.2018.11.006","article-title":"Effect of combined \u03b2-lactam\/macrolide therapy on mortality according to the microbial etiology and inflammatory status of patients with community-acquired pneumonia","volume":"155","author":"Ceccato","year":"2019","journal-title":"Chest"},{"key":"2024102404082962000_31.166.220123.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-009-1730-y"},{"key":"2024102404082962000_31.166.220123.33","doi-asserted-by":"crossref","unstructured":"Martin-Loeches I , Torres A , Nagavci B , et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia (sCAP). Eur Respir J 2022; in press [https:\/\/doi.org\/10.1183\/13993003.00735-2022].","DOI":"10.1183\/13993003.00735-2022"},{"key":"2024102404082962000_31.166.220123.34","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ157"},{"key":"2024102404082962000_31.166.220123.35","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.20.2205"},{"key":"2024102404082962000_31.166.220123.36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-268"},{"key":"2024102404082962000_31.166.220123.37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir840"},{"key":"2024102404082962000_31.166.220123.38","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203384"},{"key":"2024102404082962000_31.166.220123.39","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201407-305OC"},{"key":"2024102404082962000_31.166.220123.40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1513\/AnnalsATS.202005-558OC","article-title":"Validation of a prediction score for drug-resistant microorganisms in community-acquired pneumonia","volume":"18","author":"Ceccato","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2024102404082962000_31.166.220123.41","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201301-0079OC"},{"key":"2024102404082962000_31.166.220123.42","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03071-15"},{"key":"2024102404082962000_31.166.220123.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.04.093"},{"key":"2024102404082962000_31.166.220123.44","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy631"},{"key":"2024102404082962000_31.166.220123.45","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1513\/AnnalsATS.202107-762ED","article-title":"Too much or too little empiric treatment for Pseudomonas aeruginosa in community-acquired pneumonia?","volume":"18","author":"Torres","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2024102404082962000_31.166.220123.46","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.5.9903015"},{"key":"2024102404082962000_31.166.220123.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102153440703"},{"key":"2024102404082962000_31.166.220123.48","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2290"},{"key":"2024102404082962000_31.166.220123.49","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00134-014-3325-5","article-title":"Helmet CPAP vs oxygen therapy in severe hypoxemic respiratory failure due to pneumonia","volume":"40","author":"Brambilla","year":"2014","journal-title":"Intensive Care Med"},{"key":"2024102404082962000_31.166.220123.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503326"},{"key":"2024102404082962000_31.166.220123.51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.12402"},{"key":"2024102404082962000_31.166.220123.52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1164\/rccm.201904-0841OC","article-title":"Physiological comparison of high-flow nasal cannula and helmet noninvasive ventilation in acute hypoxemic respiratory failure","volume":"201","author":"Grieco","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404082962000_31.166.220123.53","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200645"},{"key":"2024102404082962000_31.166.220123.54","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.88"},{"key":"2024102404082962000_31.166.220123.55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4236\/pp.2011.22009","article-title":"Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings","volume":"02","author":"Sabry","year":"2011","journal-title":"Pharmacology & Pharmacy"},{"key":"2024102404082962000_31.166.220123.56","first-page":"91","article-title":"Effects of low-dose hydrocortisone in ICU patients with severe community-acquired pneumonia","volume":"55","author":"El-Ghamrawy","year":"2006","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"2024102404082962000_31.166.220123.57","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200406-808OC"},{"key":"2024102404082962000_31.166.220123.58","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.2.389"},{"key":"2024102404082962000_31.166.220123.59","doi-asserted-by":"crossref","first-page":"e16239","DOI":"10.1097\/MD.0000000000016239","article-title":"Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: a meta-analysis","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2024102404082962000_31.166.220123.60","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejcdt.2013.03.009","article-title":"Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia","volume":"62","author":"Nafae","year":"2013","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"2024102404082962000_31.166.220123.61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010406.pub2"},{"key":"2024102404082962000_31.166.220123.62","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.chest.2018.11.001","article-title":"The cost-effectiveness of corticosteroids for the treatment of community-acquired pneumonia","volume":"155","author":"Pliakos","year":"2019","journal-title":"Chest"},{"key":"2024102404082962000_31.166.220123.63","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia","volume":"48","author":"Meduri","year":"2022","journal-title":"Intensive Care Med"},{"key":"2024102404082962000_31.166.220123.64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705716"},{"key":"2024102404082962000_31.166.220123.65","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00081514"},{"key":"2024102404082962000_31.166.220123.66","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00225414"},{"key":"2024102404082962000_31.166.220123.67","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s13054-021-03840-x","article-title":"Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study","volume":"25","author":"Ceccato","year":"2021","journal-title":"Crit Care"},{"key":"2024102404082962000_31.166.220123.68","doi-asserted-by":"crossref","first-page":"e17278","DOI":"10.1097\/MD.0000000000017278","article-title":"Sphingosine-1-phosphate as an indicator for deciding the use of adjuvant corticosteroids therapy in community-acquired pneumonia (sphingosine-1-phosphate and pneumonia trial): study protocol for a randomized, placebo-controlled trial","volume":"98","author":"Hsu","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0123-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:05:32Z","timestamp":1740373532000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0123-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":68,"journal-issue":{"issue":"166","published-online":{"date-parts":[[2022,12,14]]},"published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1183\/16000617.0123-2022"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0123-2022","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]}}}